API SUPPLIERS

API Suppliers

1

US DMFs Filed

0

CEP/COS Certifications

0

JDMFs Filed

0

EU WC

0

Listed Suppliers

1

API REF. PRICE (USD / KG)

336

API Market Place

0

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

0

Europe

0

Canada

0

Australia

0

South Africa

0

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

FDF Market Place

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Full Screen View

SunWay Biotech

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

SunWay Biotech and Gnosis by Lesaffre Form Alliance to Launch MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient

Details:

The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.

Lead Product(s): Menaquinone-7,Ankascin 568-R

Therapeutic Area: Cardiology/Vascular Diseases Product Name: MenaQ7

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: Gnosis by Lesaffre

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership March 14, 2024

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Menaquinone-7

Menaquinone-7

Menaquinone-7

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

1 API Suppliers

1 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports